Loading... Please wait...

Nymox Pharmaceutical Corporation (NYMX) Financials

Currency in USD Disclaimer
$0.20 -$0 (-0.05%)
$0.2
$0.2
$0.17
$0.74
Period FY-2022 FY-2021 FY-2020 FY-2019 FY-2018 FY-2017 FY-2016 FY-2015 FY-2014 FY-2013
Period Ended 12/31/2022 12/31/2021 12/31/2020 12/31/2019 12/31/2018 12/31/2017 12/31/2016 12/31/2015 12/31/2014 12/31/2013
Operating Revenue $0.00 $0.00 $5,000.00 $116,000.00 $299,000.00 $224,000.00 $283,611.00 $2.76 M $2.95 M $3.36 M
Cost of Revenue $0.00 $0.00 $4,000.00 $58,000.00 $138,000.00 $149,000.00 $173,023.00 $160,315.00 $173,667.00 $486,154.00
Gross Profit $0.00 $0.00 $1,000.00 $58,000.00 $161,000.00 $75,000.00 $110,588.00 $2.60 M $2.78 M $2.87 M
Gross Profit Ratio 0 0 0.2 0.5 0.54 0.33 0.39 0.94 0.94 0.86
Research and Development Expenses $3.77 M $6.66 M $8.12 M $7.38 M $6.68 M $7.87 M $6.80 M $8.65 M $4.76 M $6.27 M
General & Administrative Expenses $2.88 M $5.85 M $3.60 M $6.01 M $4.13 M $5.43 M $6.18 M $11.60 M $2.82 M $1.76 M
Selling & Marketing Expenses $0.00 $0.00 $0.00 $0.00 $0.00 $8,000.00 $6,752.00 $9,528.00 $186,616.00 $282,055.00
Selling, General & Administrative Expenses $2.88 M $5.85 M $3.60 M $6.01 M $4.13 M $5.44 M $6.18 M $11.61 M $3.00 M $2.04 M
Other Expenses $113,000.00 $0.00 $0.00 $0.00 $0.00 $0.00 $0.00 $0.00 $0.00 $0.00
Operating Expenses $6.65 M $12.50 M $11.72 M $13.38 M $10.80 M $13.31 M $12.98 M $20.26 M $7.50 M $7.76 M
Cost And Expenses $6.65 M $12.50 M $11.73 M $13.44 M $10.94 M $13.46 M $13.15 M $20.42 M $7.67 M $8.24 M
Interest Income $1,000.00 $8,000.00 $27,000.00 $213,000.00 $72,000.00 $11,000.00 $3,727.00 $0.00 $361.00 $3,402.00
Interest Expense $43,000.00 $39,000.00 $42,000.00 $38,000.00 $18,000.00 $204,000.00 $233,797.00 $187,798.00 $41,913.00 $8,853.00
Depreciation & Amortization $363,000.00 $262,000.00 $294,000.00 $778,000.00 $3,000.00 $1,000.00 $3,438.00 $6,002.00 $6,649.00 $9,102.00
EBITDA -$6.29 M -$12.24 M -$11.43 M -$12.55 M -$10.57 M -$13.22 M -$12.86 M -$17.65 M -$4.79 M -$4.87 M
EBITDA Ratio 0 0 -2285.2 -108.16 -35.34 -59.03 -45.35 -6.39 -1.62 -1.45
Operating Income -$6.65 M -$12.50 M -$11.72 M -$13.33 M -$10.64 M -$13.24 M -$12.87 M -$17.66 M -$4.72 M -$4.88 M
Operating Income Ratio 0 0 -2344 -114.87 -35.59 -59.08 -45.38 -6.4 -1.6 -1.45
Total Other Income/Expenses Net $76,000.00 -$33,000.00 -$18,000.00 $163,000.00 -$7,000.00 -$1,000.00 -$10,140.00 -$45,761.00 $191,173.00 -$18,195.00
Income Before Tax -$6.58 M -$12.54 M -$11.74 M -$13.16 M -$10.59 M -$13.43 M -$13.11 M -$17.89 M -$4.65 M -$4.91 M
Income Before Tax Ratio 0 0 -2347.6 -113.47 -35.43 -59.95 -46.22 -6.48 -1.58 -1.46
Income Tax Expense -$5,000.00 $39,000.00 $42,000.00 $38,000.00 -$47,000.00 $204,000.00 $233,797.00 $187,798.00 -$52,000.00 $8,853.00
Net Income -$6.57 M -$12.58 M -$11.78 M -$13.20 M -$10.59 M -$13.43 M -$13.11 M -$17.89 M -$4.59 M -$4.91 M
Net Income Ratio 0 0 -2356 -113.79 -35.43 -59.95 -46.22 -6.48 -1.56 -1.46
EPS -0.0735 -0.15 -0.16 -0.19 -0.18 -0.26 -0.28 -0.48 -0.13 -0.14
EPS Diluted -0.0735 -0.15 -0.16 -0.19 -0.18 -0.26 -0.28 -0.48 -0.13 -0.14
Weighted Average Shares Out $89.38 M $81.98 M $73.82 M $68.85 M $60.47 M $52.65 M $46.16 M $37.40 M $35.25 M $34.15 M
Weighted Average Shares Out Diluted $89.38 M $81.98 M $73.82 M $68.85 M $60.47 M $52.65 M $46.16 M $37.40 M $35.25 M $34.15 M
Link
×
New Alert

Select an alert type

Choose sentiment spike or mentions spike or both to receive email alerts and app notification for the selected stock.
Note: Please be aware that you will receive an email only once a day, around 8:00 AM (EST), in the event of any spike.
In future if you don't want to receive any email then delete stocks added into alert section.

New Alert

Setup alert

×

Log In


or

Continue with Google Continue with Apple

Email Verification

An email with a verification code has been sent to your email address.

Welcome to StockNews!

Create Your Account

Email Verification

An email with a verification code has been sent to your email address.